Mary Szela

Mary Szela

Chief Executive Officer bei TRISALUS LIFE SCIENCES, INC.

Vermögen: 3 Mio $ am 31.03.2024

61 Jahre
Health Technology
Retail Trade
Consumer Services

Profil

Ms. Mary T.
Szela
is an Independent Director at Omega Therapeutics, Inc., an Independent Director at Kura Oncology, Inc., a President, Chief Executive Officer & Director at TriSalus Operating Life Sciences, Inc. and a President, Chief Executive Officer & Director at TriSalus Life Sciences, Inc. She is on the Board of Directors at Omega Therapeutics, Inc., Kura Oncology, Inc., TriSalus Operating Life Sciences, Inc., TriSalus Life Sciences, Inc. and Court Appointed Special Advocates of Lake County.
Ms. Szela was previously employed as an Independent Director by Prometheus Biosciences, Inc., an Independent Director by Alimera Sciences, Inc., a Chief Executive Officer & Director by Aegerion Pharmaceuticals, Inc., a Chief Executive Officer & Director by Novelion Therapeutics, Inc., an Independent Director by Coherus BioSciences, Inc., an Independent Director by Receptos, Inc., an Independent Director by Novo Nordisk A/S, a Co-Chief Executive Officer & Director by Melinta Therapeutics, Inc. /Old/, a Senior Vice President by US Pharmaceuticals, Inc., and a SVP-Global Strategic Marketing & Services by Abbott Laboratories.
She also served on the board at Senda Biosciences, Inc., Zikani Therapeutics, Inc. and Suneva Medical, Inc. She received her undergraduate degree from the University of Illinois and an MBA from the University of Illinois.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
03.04.2024 258 151 ( 0,98% ) 3 Mio $ 31.03.2024
31.05.2023 0 ( -.--% ) - $ 31.03.2024
07.06.2023 0 ( -.--% ) - $ 31.03.2024

Aktive Positionen von Mary Szela

UnternehmenPositionBeginn
KURA ONCOLOGY, INC. Director/Board Member 06.11.2018
OMEGA THERAPEUTICS, INC. Director/Board Member 01.06.2019
TRISALUS LIFE SCIENCES, INC. Chief Executive Officer 01.01.2018
Chief Executive Officer 23.01.2018
Director/Board Member -
Alle aktiven Positionen von Mary Szela

Ehemalige bekannte Positionen von Mary Szela

UnternehmenPositionEnde
PROMETHEUS BIOSCIENCES, INC. Director/Board Member 16.06.2023
COHERUS BIOSCIENCES, INC. Director/Board Member 05.08.2021
ALIMERA SCIENCES, INC. Director/Board Member 01.06.2021
Director/Board Member 01.07.2019
░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Mary Szela im Detail an

Ausbildung von Mary Szela

University of Illinois Masters Business Admin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Mary Szela im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

19

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen7
ABBOTT LABORATORIES

Health Technology

NOVO NORDISK A/S

Health Technology

ALIMERA SCIENCES, INC.

Health Technology

KURA ONCOLOGY, INC.

Health Technology

COHERUS BIOSCIENCES, INC.

Health Technology

OMEGA THERAPEUTICS, INC.

Health Technology

TRISALUS LIFE SCIENCES, INC.

Health Technology

Private Unternehmen11

Health Technology

Health Technology

Retail Trade

Health Technology

Health Technology

Health Technology

Electronic Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Mary Szela